Honegger H P, Maurer R
Chefarzt Institut für medizinische Onkologie und Hämatologie, Zürich.
Schweiz Rundsch Med Prax. 1991 Feb 26;80(9):187-9.
Collaboration of specialists is a prerequisite for the modern care of cancer patients. The 'tumor board' plays a central role. As a rule, close to 10% of all cancer patients of a hospital are reviewed by this panel. Patho-anatomic questions are settled and therapeutic plans established. A cooperative case review shortens decision paths, and therapeutic procedures are supported by all the participating specialists. The tumor board is also appreciated by postgraduate education, and it facilitates the introduction of oncologic thinking in the general hospital. For the specialist the incentive is to provide insight into his field, to expose advantages or weaknesses of his therapeutic modalities and to adapt them to the special needs of a particular patient.
专家协作是现代癌症患者护理的前提条件。“肿瘤委员会”发挥着核心作用。通常，医院所有癌症患者中近10%会由该小组进行评估。解决病理解剖问题并制定治疗计划。合作病例审查缩短了决策路径，所有参与的专家都支持治疗程序。肿瘤委员会也受到研究生教育的青睐，它有助于在综合医院引入肿瘤学思维。对于专家来说，这样做的动机是深入了解自己的领域，揭示其治疗方式的优缺点，并使其适应特定患者的特殊需求。
